Publications by authors named "Jean-Louis Gayet"

Claim this Profile
W
What Is the Real IMPACT of an Acronym?
Jean-Louis Gayet

JACC Cardiovasc Interv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the medical treatment of stable angina.
Jean-Louis Gayet, Franck Paganelli, Alain Cohen-Solal

Arch Cardiovasc Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation. A cohort study of practices.
Laurence Guédon-Moreau, Jean-Louis Gayet, Michel Galinier, Yves Frances, Hervé Lardoux

Therapie· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.
Jean Ferrières, Jean-Pierre Cambou, Jean-Louis Gayet, Marie-Annick Herrmann, Alain Leizorovicz

Int J Cardiol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Jean-Louis Gayet, Thierry Lefevre

J Invasive Cardiol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor].
Pascal Bousquet, Jean-Louis Gayet

Therapie· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Jean-Louis Gayet,

J Hypertens· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OPTIMAAL trial: losartan or captopril after acute myocardial infarction.
Jean-Louis Gayet,

Lancet· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis